Solving the PCT Priority problem
The ‘joint applicants’ approach to PCT applications would provide an elegant solution to issues of who is entitled to priority claims in PCT applications, suggests Chiara Banas of EIP.
- When alliances fail, is arbitration the answer? 24-02-2022
- Why mentorship matters 25-01-2022
- A guide for life sciences entrepreneurs 22-12-2021
- UK experimental use exemptions: part 1—the original 15-07-2021
- Got a patent, now where to validate? 22-03-2021
Latest big pharma news
Roche and Bluebird settle ‘Spark’ TM suit
19-05-2022
Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease.
